Deepverge PLC Investor presentation and corporate update (3755G)
25 November 2020 - 6:00PM
UK Regulatory
TIDMDVRG
RNS Number : 3755G
Deepverge PLC
25 November 2020
25 November 2020
DeepVerge PLC
("DeepVerge" or "the Company")
Investor presentation and corporate update following Modern
Water plc acquisition
DeepVerge (LSE:DVRG.L), the scientific research and
AI-as-a-Service company, is pleased to announce that Gerry Brandon,
Chief Executive Officer, will be presenting at an investor webinar
being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox
Markets.
The event will be held on Tuesday 1(st) December 2020 at 2pm.
Please register your interest at
https://voxmarkets.brand.live/c/deepverge-webinar
Gerard Brandon, CEO of DeepVerge, Commented:
"Deepverge is expanding, with organic revenue growth alone,
despite COVID, guided at GBP4m for 2020, including an increase in
revenues by 300% in H2 2020, up from GBP1m in H1 2020. Following
the recent acquisition of Modern Water plc, we will now have sales
offices and laboratories for Labskin and Rinocloud AI services in
the US, Ireland, UK, China and Japan. This global expansion
provides access to a growing list of household name clients, that
includes Unilever, L'Oréal, Estee Lauder, Walgreens Boots Alliance,
Amway and L'Occitane, cross-selling products and services from each
division and serving the environment, cosmetics and pharma sectors
worldwide.
"The presentation will provide an update on sales, marketing,
supply chain management of products and services under development
in a post-COVID world with insight into what is expected to come in
2021 and 2022."
For further information please contact:
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments (TPI) +44 (0) 20 3657
Limited (Broker) Andy Thacker/Zoe Alexander 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is a scientific research and AI-as-a-Service company
focused on production and analysis of bacteria, virus and toxins
utilising artificial intelligent data analytics in regulatory
technology, from scientifically proving the impact of skincare
product claims on skin microbiome for top 20 global cosmetic
company clients to remotely detecting water contamination in
real-time.
In November 2020, DeepVerge acquired Modern Water who developed
and commercialised a cutting-edge technology, focused on monitoring
of contaminated water and decontamination of wastewater, making
recycling of water more efficient. Six countries across the world
have legislated that Modern Water monitoring test systems are
written into their environmental protection legislation. The
Company is in final trials for its real-time contamination product,
Microtox PD, for the identification of COVID-19 hotspots and other
pathogens.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCQZLFLBFLFFBL
(END) Dow Jones Newswires
November 25, 2020 02:00 ET (07:00 GMT)
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2024 to May 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From May 2023 to May 2024